Kelun-Biotech’s WIN378 Advances to Phase 3 in Asthma
Chengdu, China, September 8, 2026 Kelun-Biotech has announced positive interim results from the Phase 2 portion of the global...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Chengdu, China, September 8, 2026 Kelun-Biotech has announced positive interim results from the Phase 2 portion of the global...
Sunnyvale, California, U.S., September 8, 2026 Anitoa Systems, LLC has announced the integration of secure cloud connectivity and enterprise-grade...
